The sequential treatment approach to resistant schizophrenia with risperidone and clozapine: Results of an open study with follow-up

Human Psychopharmacology

Volumn 13, Issue 2, 1998, Pages 91-97

  Cavallaro, R ^a   Brambilla, P ^a   Smeraldi, E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Clozapine; Drug resistant; Risperidone; Schizophrenia; Treatment

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; AGITATION; AKATHISIA; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HOSPITALIZATION; HUMAN; MALE; PRIORITY JOURNAL; RELAPSE; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 0031886624     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199803)13:2<91::AID-HUP949>3.0.CO;2-C     Document Type: Article

References (14)

1. Andreasen, N. C. (1983). Negative symptoms in schizophrenia: definition and reliability. Archives of General Psychiatry, 39, 789-794.
2. Andreasen, N. C. (1984). Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa, Iowa City, IA.
3. Buchanan, R. W. (1995). Clozapine, efficacy and safety. Schizophrenia Bulletin, 21(4), 579-591.
4. Carpenter, W. T., Conley, R. R., Buchanan, R. W., Breier, A. and Tamminga, C. A. (1995). Patient response and resource management: another view of clozapine treatment of schizophrenia. American Journal of Psychiatry, 152(6), 827-832.
5. Cavallaro, R., Colombo, C. and Smeraldi, E. (1995a). A pilot, open study of the treatment of refractory schizophrenia with risperidone and clozapine. Human Psychopharmacology, 10, 231-234.
6. Cavallaro, R., Colombo, C. and Smeraldi, E. (1995b). The treatment of resistant schizophrenia: a pilot, open study on the treatment with risperidone and clozapine. In: Critical Issues in the Treatment of Schizophrenia, Racagni, G., Brunello, N., Langer, S. Z. and Mendlewicz, J. (Eds), International Academy for Biomedical Drug Research, Karger, Basel, pp. 178-181.
7. Kane, J. M. (1996). Schizophrenia. New England Journal of Medicine, 334(1), 34-41.
8. Kane, J. and Marder, S. (1993). Psychopharmacologic treatment of schizophrenia. Schizophrenia Bulletin, 19(2), 287-302.
9. Kane, J., Honigfeld, G. and Singer, J. (1988). Clozapine for the treatment of resistant schizophrenics. Archives of General Psychiatry, 45, 789-796.
10. Meltzer, H. J. (1994). An overview of the mechanism of action of clozapine. Journal of Clinical Psychopharmacology, 55(9), suppl. B: 47-52.
11. Mendelowitz, A. J. and Liebermann, J. A. (1995). New findings in the use of atypical antipsychotics drugs. I: focus on risperidone. Journal of Clinical Psychiatry Case and Comment Series, 2, 1.
12. Overall, J. E. and Gorhamm, D. R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799-812.
13. Raza, A., Ettinger, T. and Sharif, Z. A. (1995). A comparison of the efficacy of clozapine and risperidone in treatment refractory schizophrenia. In: New Research Program and Abstracts of the 148th Annual Meeting of the American Psychiatric Association, May 23, 1995, Miami Fla Abstract no. 228: 117.
14. Wilson, W. H. (1996). Time required for initial improvement during clozapine treatment of refractory schizophrenia. American Journal of Psychiatry, 153, 951-952.